Engineering extracellular vesicles for targeted therapeutic delivery in the heart
Bioscience Reports · 22.04.2026 · 46 (4)
DOI: 10.1042/bsr20254075 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioscience Reports, online erschienen am 22.04.2026. Verfasst von Iqra Anwar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Mandel Center for Heart and Vascular Research, and the Duke Cardiovascular Research Center, Duke University Medical Center, Durham, NC 27710, U.S.A. Hauptthemen laut MEDLINE: Extracellular Vesicles, Drug Delivery Systems, Heart Failure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Heart failure is a leading cause of morbidity and mortality, highlighting the need for improved therapeutic strategies. Critical to the success of therapies is efficient and targeted delivery systems. Extracellular vesicle-based delivery systems have emerged as promising candidates due to their biocompatibility and low immunogenicity. While extracellular vesicles from a wide variety of cells have been used, they have demonstrated divergent effects on the heart. The present review first summarizes the current sources of extracellular vesicles employed in heart failure therapy and their contrasting outcomes. The review then examines the view that these contrasting outcomes arise from limited cell specificity, inefficient delivery, and suboptimal cargo loading. Finally, the review discusses how these problems are being dealt with by recent advances, including genetic modification, chemical functionalization, and enhanced loading strategies. Together, these approaches highlight the potential of extracellular vesicle-based systems as precision therapeutics in cardiovascular medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mandel Center for Heart and Vascular Research, and the Duke Cardiovascular Research Center, Duke University Medical Center, Durham, NC 27710, U.S.A.
- Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin 10129, Italy.
ORCID-Profile: Conrad P Hodgkinson
Förderung
- NHLBI NIH HHS
Zitieren
APA
Anwar, I., Wang, X., Parlongo, S., Harris, S., Pratt, R. E., Dzau, V. J., & Hodgkinson, C. P. (2026). Engineering extracellular vesicles for targeted therapeutic delivery in the heart. Bioscience Reports, 46(4). https://doi.org/10.1042/bsr20254075
Vancouver
Anwar I, Wang X, Parlongo S, Harris S, Pratt RE, Dzau VJ, et al. Engineering extracellular vesicles for targeted therapeutic delivery in the heart. Bioscience Reports. 2026;46(4). doi:10.1042/bsr20254075
BibTeX
@article{Anwar2026,
author = {Anwar, Iqra and Wang, Xinghua and Parlongo, Saverio and Harris, Sonalí and Pratt, Richard E and Dzau, Victor J and Hodgkinson, Conrad P},
title = {Engineering extracellular vesicles for targeted therapeutic delivery in the heart},
journal = {Bioscience Reports},
year = {2026},
volume = {46},
number = {4},
doi = {10.1042/bsr20254075}
}
EUVIMED